Valens Signs Multi-Year Cannabis Extraction and Product R&D KELOWNA, BC, Nov. 14, 2018 /PRNewswire/ Valens GroWorks Corp. (CSE: VGW) (OTC-QB: MYMSF) (the Company or Valens), a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has entered into a multi-year Extraction Services Agreement (the Agreement) with Harvest One (TSXV:HVT) for cannabis extraction and value-added services. Under the terms of the Agreement, Harvest Ones subsidiary, United Greeneries, will ship bulk quantities of dried cannabis to Valens over an initial three-year term. The Company will receive and process the cannabis on a fee for service basis into bulk resin or other cannabis oil derivative products. The Company will also conduct R&D services for Harvest One to support their product line development including health and wellness products, beverages, vape pens, and nutraceuticals using cannabis oil derivative products. The significance of these products is reflected in the more developed markets in the United States where raw flower makes up less than half of the products sold. We are excited for the opportunity to utilize our extraction services and R&D technology platform to support Harvest One in delivering innovative, high quality consumer packaged goods to the market, said Tyler Robson, CEO of Valens. Valens expertise in both cannabis extraction and cannabis derivatives offers Harvest One a competitive advantage in the marketplace, especially considering the proven consumer uptake and shelf life stability benefits we are able to make available through the use of SRSE technology. The team at Valens intends to work closely with Harvest One to put the best possible products on the shelves for Canadian consumers. Harvest Ones agreement with Valens represents a valuable opportunity to accelerate our product development strategy. We are excited to leverage Valens industry leading expertise to further expand our recreational, and health and wellness products, under United Greeneries, Satipharm and Dream Water. Grant Froese, CEO of Harvest One Furthermore, this partnership gives Harvest One the ability to diversify our medical product offerings to better serve our patients.